Edgestream Partners L.P. trimmed its position in Eli Lilly and Company (NYSE:LLY – Free Report) by 73.6% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,029 shares of the company’s stock after selling 2,867 shares during the period. Edgestream Partners [...]